Millennium Management LLC Invests $574,000 in LifeVantage Co. (NASDAQ:LFVN)

Millennium Management LLC acquired a new position in LifeVantage Co. (NASDAQ:LFVN) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 32,723 shares of the company’s stock, valued at approximately $574,000. Millennium Management LLC owned 0.26% of LifeVantage at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in LFVN. LPL Financial LLC boosted its holdings in LifeVantage by 301.0% in the fourth quarter. LPL Financial LLC now owns 211,039 shares of the company’s stock worth $3,700,000 after purchasing an additional 158,405 shares during the period. Ancora Advisors LLC acquired a new position in LifeVantage in the fourth quarter worth $1,138,000. EAM Investors LLC acquired a new position in LifeVantage in the fourth quarter worth $1,056,000. Susquehanna International Group LLP lifted its stake in LifeVantage by 83.5% in the fourth quarter. Susquehanna International Group LLP now owns 128,082 shares of the company’s stock valued at $2,245,000 after buying an additional 58,279 shares during the last quarter. Finally, 683 Capital Management LLC bought a new stake in LifeVantage in the fourth quarter valued at $868,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

LifeVantage Stock Performance

LFVN stock opened at $12.52 on Monday. The stock has a market capitalization of $157.60 million, a price-to-earnings ratio of 22.36 and a beta of 0.43. LifeVantage Co. has a 1 year low of $5.22 and a 1 year high of $27.38. The stock’s fifty day moving average is $13.04 and its two-hundred day moving average is $16.24.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.10. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%. The business had revenue of $58.44 million for the quarter, compared to analysts’ expectations of $60.99 million.

LifeVantage Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a $0.045 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.18 dividend on an annualized basis and a yield of 1.44%. This is a boost from LifeVantage’s previous quarterly dividend of $0.04. LifeVantage’s dividend payout ratio (DPR) is currently 26.09%.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.